Docosahexaenoic acid-rich fish oil does not affect serum lipid concentrations of normolipidemic young adults. 1996

T Hamazaki, and S Sawazaki, and E Asaoka, and M Itomura, and Y Mizushima, and K Yazawa, and T Kuwamori, and M Kobayashi
The First Department of Internal Medicine, Toyama Medical and Pharmaceutical University, Japan.

Fish oils, purified eicosapentaenoic acid and docosahexaenoic acid (DHA) have been reported to improve blood lipid concentrations, especially those of triglycerides in humans. However, to our knowledge there have been no double-blind studies investigating the effects of DHA-rich fish oil on blood lipid concentrations. Therefore, we conducted a placebo-controlled double-blind study. Twenty-four healthy, normolipidemic young adults took either DHA-rich fish oil capsules containing 1.5-1.8 g of DHA or control oil capsules containing 97% soybean oil and 3% fish oil for 13 wk. Blood samples were taken at the start and end of the study, and serum lipids concentrations were compared. There were no significant changes over time in the DHA group in the following serum lipids: total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, lipoprotein(a), and apolipoproteins A1 and B. In contrast, apolipoprotein A1 concentrations slightly (10%) but significantly increased over time in the control group. Docosahexaenoic acid at a dose of less than 2 g/d did not change serum lipid concentrations of normolipidemic subjects. The effects of DHA in hyperlipidemic patients remain to be investigated in a double-blind study.

UI MeSH Term Description Entries
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008078 Cholesterol, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol. LDL Cholesterol,Cholesteryl Linoleate, LDL,LDL Cholesteryl Linoleate,Low Density Lipoprotein Cholesterol,beta-Lipoprotein Cholesterol,Cholesterol, beta-Lipoprotein,beta Lipoprotein Cholesterol
D008297 Male Males
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D004281 Docosahexaenoic Acids C22-unsaturated fatty acids found predominantly in FISH OILS. Docosahexaenoate,Docosahexaenoic Acid,Docosahexenoic Acids,Docosahexaenoic Acid (All-Z Isomer),Docosahexaenoic Acid Dimer (All-Z Isomer),Docosahexaenoic Acid, 3,6,9,12,15,18-Isomer,Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer),Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Cerium Salt,Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Cesium Salt,Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Potassium Salt,Docosahexaenoic Acid, 4,7,10,13,16,19-(Z,Z,Z,Z,Z,E-Isomer),Docosahexaenoic Acid, 4,7,10,13,16,19-Isomer,Docosahexaenoic Acid, 4,7,10,13,16,19-Isomer, Sodium Salt,Docosahexaenoic Acid, Sodium Salt,Acid, Docosahexaenoic,Acids, Docosahexaenoic,Acids, Docosahexenoic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked

Related Publications

T Hamazaki, and S Sawazaki, and E Asaoka, and M Itomura, and Y Mizushima, and K Yazawa, and T Kuwamori, and M Kobayashi
March 2020, Nutrients,
T Hamazaki, and S Sawazaki, and E Asaoka, and M Itomura, and Y Mizushima, and K Yazawa, and T Kuwamori, and M Kobayashi
November 1996, European journal of clinical nutrition,
T Hamazaki, and S Sawazaki, and E Asaoka, and M Itomura, and Y Mizushima, and K Yazawa, and T Kuwamori, and M Kobayashi
May 2008, The British journal of nutrition,
T Hamazaki, and S Sawazaki, and E Asaoka, and M Itomura, and Y Mizushima, and K Yazawa, and T Kuwamori, and M Kobayashi
January 2012, Biological psychology,
T Hamazaki, and S Sawazaki, and E Asaoka, and M Itomura, and Y Mizushima, and K Yazawa, and T Kuwamori, and M Kobayashi
December 1997, Lipids,
T Hamazaki, and S Sawazaki, and E Asaoka, and M Itomura, and Y Mizushima, and K Yazawa, and T Kuwamori, and M Kobayashi
April 2020, Nutrients,
T Hamazaki, and S Sawazaki, and E Asaoka, and M Itomura, and Y Mizushima, and K Yazawa, and T Kuwamori, and M Kobayashi
December 2006, Clinical nutrition (Edinburgh, Scotland),
T Hamazaki, and S Sawazaki, and E Asaoka, and M Itomura, and Y Mizushima, and K Yazawa, and T Kuwamori, and M Kobayashi
July 1998, American journal of veterinary research,
T Hamazaki, and S Sawazaki, and E Asaoka, and M Itomura, and Y Mizushima, and K Yazawa, and T Kuwamori, and M Kobayashi
May 2013, Metabolism: clinical and experimental,
T Hamazaki, and S Sawazaki, and E Asaoka, and M Itomura, and Y Mizushima, and K Yazawa, and T Kuwamori, and M Kobayashi
January 1999, Lipids,
Copied contents to your clipboard!